Editor’s note: The physician narrator in this article is a fictional composite created from common clinical experiences and evidence-based medical guidance. No individual patient or physician is being portrayed. Details have been combined or changed to protect privacy.
I once believed that the hardest part of prescribing an opioid was choosing the correct medication and dose. I had a medical license, a tidy electronic chart, and several years of training that had taught me how receptors, metabolism, and drug interactions worked. Surely the rest was just responsible decision-making.
Then opioids taught me an uncomfortable lesson: Pharmacology may fit neatly into a textbook, but pain does not. Neither do fear, dependence, addiction, grief, disability, or the desperate wish to feel normal for one afternoon.
My education came from both sides of the prescription pad. I prescribed opioids to patients with severe injuries, postoperative pain, and disabling chronic conditions. Years later, after surgery of my own, I took them. That experience did not turn me into an expert on every patient’s suffering. It did, however, make me less impressed with my clipboard and more interested in the person sitting across from it.
When the prescription pad felt deceptively simple
Early in my career, I saw opioids mainly as tools. A patient had pain; a medication reduced pain. The equation appeared refreshingly straightforward, especially compared with the less glamorous alternatives: weeks of physical therapy, insurance authorization battles, sleep treatment, behavioral support, workplace accommodations, and lifestyle changes that nobody could fit into a seven-minute appointment.
Opioids could work quickly. That mattered. A patient with a fractured ankle or severe pain after surgery did not need a lecture about mindfulness while attempting to levitate three inches above the examination table. Appropriate opioid treatment can be an important part of compassionate medical care.
The problem was not that opioids never worked. The problem was that their immediate effect could make the larger clinical picture look simpler than it was.
A pain score might fall from nine to five, yet the patient could remain unable to sleep, work, exercise, or care for a child. Another patient might report excellent relief while gradually developing tolerance, sedation, constipation, or increasing anxiety about the next dose. Someone else might take the same prescription for three days, stop without difficulty, and wonder what all the fuss was about.
Medicine loves averages. Patients insist on being individuals.
The day I became the patient
My personal encounter with prescription opioids followed surgery. I woke with a dry mouth, a bandage, and the conviction that someone had parked a delivery truck on the relevant body part. The nurse asked me to rate my pain from zero to ten. I wanted to request a more expressive scale, perhaps one involving weather emergencies.
The first opioid dose reduced the pain substantially. It also made me sleepy and vaguely detached. The sharp edges of the room softened. I understood immediately why these medications can feel like rescue.
At home, I followed the label carefully. Even so, several side effects arrived without an appointment. My thinking slowed. My balance felt less dependable. My digestive system apparently entered witness protection. I began planning my day around the medication schedule, not because I was chasing euphoria, but because I feared the pain that might return before the next dose.
That fear surprised me.
I had treated patients who watched the clock in exactly the same way. In the clinic, clock-watching could look suspicious when documented in a chart. From my couch, it felt more complicated. Was I displaying drug-seeking behavior, or was I trying to avoid another wave of pain? Was I dependent, addicted, anxious, undertreated, or simply human?
The answer was that one observation could not settle the question. Context mattered. Patterns mattered. Function, control, consequences, duration, and the patient’s goals mattered.
Physical dependence is not the same as opioid use disorder
One of the most important lessons in opioid care is that physical dependence and opioid use disorder are related concepts, but they are not interchangeable.
Physical dependence can occur when the body adapts to repeated opioid exposure. Abruptly stopping or sharply reducing the medication may then produce withdrawal symptoms. Tolerance may also develop, meaning a person needs a different dose to achieve the same effect. These physiological adaptations can occur even when a medication is taken exactly as prescribed.
Opioid use disorder, by contrast, involves a problematic pattern of opioid use that causes significant impairment or distress. Warning signs may include loss of control, compulsive use, continued use despite harm, intense craving, or repeated failure to meet major responsibilities.
The distinction is not merely academic. Calling every physically dependent patient “addicted” can produce shame, damage trust, and lead to unsafe care. At the same time, avoiding an honest discussion when opioid use has become compulsive can delay lifesaving treatment.
Good medicine requires enough humility to evaluate the whole pattern rather than assigning a label after one uncomfortable conversation.
The patient whose call changed my practice
One patient remains vivid in my memory, although the details here are intentionally blended with other experiences. I will call him Daniel.
Daniel had chronic back pain after years of physical labor. Imaging showed real abnormalities, although scans could not measure the exhaustion in his face or the humiliation of needing help putting on his shoes. He had tried several treatments with mixed results. Opioids helped him remain active, but his dose had gradually increased.
When new safety policies arrived, our conversations became tense. I worried about overdose, sedation, medication combinations, and long-term harm. Daniel worried that I had stopped believing him. Both concerns were legitimate, but I handled mine as a clinical problem and heard his as resistance.
I began reducing his medication. The plan may have looked defensible in the chart, but the communication was poor and the pace did not feel collaborative to him. He missed appointments. I interpreted that as nonadherence. He interpreted my office as another place where pain made him a suspect.
Months later, I learned that he had obtained pills outside the medical system. What he believed was a familiar prescription product was not what he thought it was. He survived an overdose because someone nearby had naloxone and called for emergency help.
The news landed like a stone.
I was not solely responsible for Daniel’s choices or for a dangerous illicit drug supply. Yet I could not hide behind that truth. I had treated risk reduction as something I did to a patient rather than something we built together. I had focused on the medication and underestimated the rupture in trust.
What responsible opioid prescribing looks like now
My approach eventually changed from “How do I control this prescription?” to “How do we improve function and reduce harm?” That question is broader, slower, and occasionally inconvenient. It is also much more useful.
Begin with goals larger than a pain score
Before starting or continuing opioid therapy, I ask what the patient hopes to regain. Is the goal to walk to the mailbox, return to work, sleep for six hours, attend a child’s graduation, or complete rehabilitation after surgery?
Pain intensity matters, but function provides essential context. A medication that lowers a numerical score while causing disabling sedation may not be a clinical victory. Conversely, modest pain relief that enables movement, sleep, and social connection can be meaningful.
Use nonopioid treatments without pretending they are magic
Depending on the condition, a care plan may include acetaminophen, anti-inflammatory medication, certain antidepressants or anticonvulsants, topical therapies, injections, physical therapy, graded activity, psychological support, sleep treatment, or other interventions.
These options should not be presented as consolation prizes. They also should not be oversold. Physical therapy may help, but it does not reverse every structural problem. Behavioral treatment can improve coping and function, but suggesting it carelessly may sound like, “Your pain is imaginary; please breathe differently.”
The language matters. I now explain that pain is biological, psychological, and social because human beings are biological, psychological, and socialnot because the pain is unreal.
Discuss benefits, risks, and an exit strategy
Before prescribing, patients deserve a clear explanation of expected benefits, common side effects, safe storage, driving risks, dangerous medication combinations, and what will happen if treatment is ineffective.
An exit strategy is not pessimism. It is informed consent. For acute pain, many patients need opioids only briefly. For longer treatment, regular reassessment helps determine whether benefits continue to outweigh risks.
Avoid abrupt, one-size-fits-all tapers
When a patient has taken opioids regularly, sudden discontinuation can cause withdrawal, worsening pain, psychological distress, loss of trust, or unsafe attempts to obtain relief elsewhere. Unless an immediate safety emergency requires rapid action, changes should generally be individualized and discussed with the patient.
A taper is not just arithmetic. It is a clinical process involving symptoms, function, fears, alternatives, and follow-up.
Use monitoring as a seat belt, not a courtroom
Prescription monitoring data, medication reviews, toxicology testing, follow-up visits, and screening for mental health or substance-use concerns can improve safety. They work best when presented as routine tools rather than traps.
I explain why I am checking. I invite questions. Unexpected findings require discussion, confirmation when appropriate, and clinical judgment. A laboratory result is information, not a complete biography.
Naloxone belongs in ordinary medical conversations
I once worried that offering naloxone would insult patients. I imagined them hearing, “I think you are irresponsible.” In reality, the better comparison is a fire extinguisher. Owning one does not mean you plan to set the kitchen on fire.
Naloxone can rapidly reverse an opioid overdose. It is available in easy-to-use formulations, including nasal sprays, and can be administered by people without formal medical training. Patients, relatives, roommates, and caregivers should know where it is stored and how to recognize possible overdose signs, including unresponsiveness, very slow or absent breathing, and blue or gray lips or fingertips.
Administering naloxone does not replace emergency care. Its effects can wear off while an opioid remains active, so emergency services are still necessary.
I now discuss naloxone matter-of-factly, especially when risk is elevated by higher opioid exposure, a history of overdose or substance use disorder, reduced tolerance, respiratory disease, or use of other sedating substances. The conversation is usually shorter and less awkward than explaining the office parking rules.
Medication treatment for opioid use disorder is real treatment
Another major change in my practice was learning to discuss medications for opioid use disorder without apology. Buprenorphine, methadone, and naltrexone are established treatment options. They are not evidence of weak character, and using medication is not simply “replacing one drug with another.”
These medications work in different ways. Treatment selection depends on the patient’s clinical situation, preferences, treatment history, access, and goals. Counseling and social support can be valuable, but medication should not be withheld merely because every ideal service is unavailable.
I have watched patients return to work, rebuild relationships, and stop organizing every waking hour around avoiding withdrawal. Recovery rarely resembles a movie montage. It may involve missed visits, changed doses, relapses, new starts, housing problems, grief, and paperwork sturdy enough to qualify as a construction material.
Progress can still be real.
Stigma enters the room before the physician does
Patients with opioid use disorder often expect contempt because many have already encountered it. Words such as “junkie,” “abuser,” “clean,” or “dirty” reduce a person to a diagnosis or laboratory result. Even clinical notes can carry judgment through phrases such as “drug-seeking” when the observed behavior may have multiple explanations.
More precise language improves care. I can document that a patient requested a medication by name, took more than prescribed, experienced withdrawal, or continued using despite specific harms. Those statements describe behavior. They do not pretend to know the person’s moral worth.
Compassion does not require ignoring risk. Boundaries, careful prescribing, and honest diagnoses remain essential. The goal is not to become permissive. The goal is to remain therapeutic.
The illicit fentanyl era changed the stakes
Today’s opioid environment is not limited to medications dispensed by licensed pharmacies. Counterfeit pills may be made to resemble familiar prescription products while containing illicitly manufactured fentanyl or other unexpected substances. Their appearance cannot reliably reveal their contents.
That reality changed the advice I give. A pill obtained from a friend, dealer, website, or social-media contact is not made safer by carrying a recognizable imprint. Patients who use opioids outside medical care need practical harm-reduction information, access to naloxone, and a clear path to treatment without humiliation.
Some clinicians worry that harm reduction condones drug use. I view it differently. Seat belts do not endorse collisions. Clean syringes do not celebrate injection. Naloxone does not approve of overdose. These tools acknowledge that a person must remain alive to recover.
Five experiences that reshaped my understanding of opioids
The following moments capture the practical lessons that changed me most. Together, they represent the additional experience that no lecture, warning label, or continuing-education quiz could fully provide.
1. The postoperative night when I feared the next wave of pain
As a patient, I discovered that anticipation could be nearly as powerful as pain itself. I watched the clock because I remembered how much the previous dose had helped and worried about what would happen when it wore off. That did not mean I had developed opioid use disorder overnight. It meant I needed a clear plan.
My surgeon’s office helped me alternate appropriate nonopioid medication, use ice, adjust activity, and gradually increase the interval between opioid doses. Knowing what to expect reduced my anxiety. The plan did not eliminate discomfort, but it turned an open-ended threat into a manageable recovery process.
I now give patients that same roadmap whenever possible. “Take as needed” is technically concise but emotionally vague. People do better when they understand likely pain patterns, medication limits, warning signs, and how to step down treatment.
2. The patient who taught me not to confuse calmness with low pain
A woman with advanced arthritis once described severe pain in an almost conversational tone. She did not grimace or raise her voice. A rushed observer might have concluded that her reported pain was exaggerated.
Then she explained that she had lived with it for years and had learned not to display distress because visible suffering made other people uncomfortable. Her calmness was adaptation, not proof of comfort.
That encounter made me more cautious about judging pain by performance. Some patients cry. Some joke. Some become angry. Some sit perfectly still and apologize for taking your time. Behavior matters, but it must be interpreted within a broader clinical story.
3. The refill request that was really a sleep problem
Another patient repeatedly requested an evening opioid dose. My first instinct was to focus on misuse risk. A longer conversation revealed that pain woke him whenever he rolled onto the affected shoulder. He was not primarily seeking intoxication; he was seeking four consecutive hours of sleep.
We addressed positioning, nighttime movement, rehabilitation, and a nonopioid strategy. His requests decreased because we had finally treated the problem hidden inside the request.
Not every early refill has an innocent explanation, but every request deserves investigation before interpretation becomes accusation.
4. The overdose survivor who disliked being called lucky
A patient once told me that everyone called him lucky after an overdose. He did not feel lucky. He felt frightened, ashamed, and responsible for the terror experienced by the person who found him.
He said the word “lucky” made the event sound finished, as though survival had solved the illness. In truth, surviving created the next urgent question: What support would keep him alive tomorrow?
We discussed medication treatment, naloxone, triggers, housing instability, and follow-up. The plan was imperfect because his life was complicated. Still, he returned. Sometimes the first measurable success in addiction care is not abstinence. It is another conversation.
5. The moment I stopped trying to win
Opioid conversations can become contests. The physician tries to prove that a dose is unsafe. The patient tries to prove that the medication is necessary. Both participants gather evidence while trust quietly leaves through the side door.
I eventually stopped trying to win. I began saying, “I believe you are in pain, and I am also concerned about safety. We need a plan that respects both facts.”
That sentence does not magically resolve disagreement. It does establish that pain and risk can coexist. Patients do not have to prove perfect innocence to deserve relief, and physicians do not have to promise zero pain to provide compassionate care.
The work is to stay in the conversation long enough to build something safer.
What I wish every physician understood
I wish we understood earlier that prescribing less is not automatically the same as practicing better medicine. Sometimes fewer opioids are safer and more effective. Sometimes a carefully managed opioid remains appropriate. Sometimes an existing regimen should be changed slowly. Sometimes the urgent priority is diagnosing opioid use disorder and offering medication treatment. Sometimes it is placing naloxone in a family member’s hands before the patient leaves the building.
The correct decision depends on the condition, the patient, the expected benefit, the risks, available alternatives, and the consequences of changing course.
I also wish patients knew that a safety conversation is not necessarily an accusation. Asking about alcohol, sedatives, prior overdose, mental health, or medication storage can feel intrusive. These questions help clinicians identify preventable danger.
At the same time, physicians must earn the trust required to ask them. Trust is not created by wearing a white coat and typing rapidly while maintaining heroic eye contact with a computer monitor.
Conclusion: The lesson was never simply “opioids are bad”
My personal story with opioids did not leave me believing that these medications are villains. It left me believing that they are powerful, complicated tools operating inside powerful, complicated human lives.
Opioids can relieve severe pain. They can also cause sedation, dependence, overdose, and opioid use disorder. Restricting them without individualized care can create additional harm, just as prescribing them without thoughtful assessment can. The physician’s responsibility is not to choose between compassion and caution. It is to practice both at the same time.
Be curious before becoming suspicious. Measure function, not merely numbers. Discuss naloxone without shame. Treat opioid use disorder with evidence-based medication. Avoid abrupt abandonment. Remember that a patient’s story is clinical information, not background noise.
Most importantly, leave enough room in the appointment to hear what the prescription cannot explain.
